Published in Tumour Biol on January 26, 2012
Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis. PLoS One (2013) 0.92
A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer. Transl Oncol (2015) 0.79
Meta-analysis of the prognostic value of smad4 immunohistochemistry in various cancers. PLoS One (2014) 0.78
TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells. PLoS One (2017) 0.78
Relationships between SMAD3 expression and preoperative fluoropyrimidine-based chemoradiotherapy response in locally advanced rectal cancer patients. World J Surg (2015) 0.76
Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis. BMC Cancer (2017) 0.75
Activins and their related proteins in colon carcinogenesis: insights from early and advanced azoxymethane rat models of colon cancer. BMC Cancer (2016) 0.75
Negative feedback loop between ZBTB7A and TGF-β in breast cancer. Oncol Lett (2017) 0.75
Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nat Rev Drug Discov (2007) 2.67
The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis. Cardiovasc Drugs Ther (2012) 2.22
Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. J Pathol (2002) 2.04
Molecular medicine: a lifetime of learning, teaching and caring. Trends Mol Med (2005) 2.02
Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol (2006) 1.80
Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior. Cancer Res (2007) 1.79
Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21. Mol Med (2011) 1.73
Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol (2009) 1.67
Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol (2006) 1.52
Estrogen receptor alpha/beta, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance? Int J Colorectal Dis (2009) 1.51
p53-dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions. Lab Invest (2005) 1.49
Colorectal cancer stem cells. Stem Cells (2012) 1.47
Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med (2006) 1.44
The alpha2B adrenergic receptor deletion/insertion polymorphism in morbid obesity. Clin Auton Res (2003) 1.43
Different Prognostic Significance of Cardiac Troponin at Presentation and Peak Cardiac Troponin in Patients with Non-ST Segment Elevation Myocardial Infarction. Cardiology (2016) 1.40
Mechanotransduction in osteoblast regulation and bone disease. Trends Mol Med (2009) 1.32
Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice. Diabetes (2011) 1.30
Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol (2005) 1.28
Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors. Lancet Oncol (2009) 1.27
Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab (2007) 1.26
TGF-beta signalling in colon carcinogenesis. Cancer Lett (2011) 1.26
Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis. Cell Res (2007) 1.24
Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis (2012) 1.24
Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis. Cardiovasc Intervent Radiol (2012) 1.21
Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas. J Pathol (2004) 1.20
Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities. Proc Natl Acad Sci U S A (2012) 1.19
The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells. J Biol Chem (2002) 1.18
Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients. Cardiovasc Intervent Radiol (2010) 1.17
Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease. Neuromolecular Med (2014) 1.13
Amyand's hernia: a case report. World J Gastroenterol (2006) 1.11
Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease. Int J Cardiol (2012) 1.10
Runx2: of bone and stretch. Int J Biochem Cell Biol (2007) 1.09
Emergency liver resection for combined biliary and vascular injury following laparoscopic cholecystectomy: case report and review of the literature. South Med J (2007) 1.09
Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis (2008) 1.07
Role of vitamin D in atherosclerosis. Circulation (2013) 1.07
p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner. EMBO J (2003) 1.06
Expression of p21waf1/Cip1 in stromal fibroblasts of primary breast tumors. Hum Mol Genet (2008) 1.05
PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas. J Cancer Res Clin Oncol (2005) 1.04
Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy. Expert Opin Investig Drugs (2012) 1.04
The NF-κB signalling pathway in osteoarthritis. Int J Biochem Cell Biol (2013) 1.04
Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. J Crohns Colitis (2011) 1.04
Acceleration of wound healing by growth hormone-releasing hormone and its agonists. Proc Natl Acad Sci U S A (2010) 1.03
Laparoscopic gastric plication for the treatment of morbid obesity: a review. Minim Invasive Surg (2012) 1.03
Signaling networks and transcription factors regulating mechanotransduction in bone. Bioessays (2009) 1.03
Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog (2009) 1.02
Growth hormone-releasing hormone: not only a neurohormone. Trends Endocrinol Metab (2011) 1.02
DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer. J Mol Med (Berl) (2013) 1.02
Two-trocar laparoscopic-assisted appendectomy versus conventional laparoscopic appendectomy in patients with acute appendicitis. J Laparoendosc Adv Surg Tech A (2006) 1.02
Hydrogen bonds in protein-DNA complexes: where geometry meets plasticity. Biochimie (2007) 1.01
FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk. Int J Colorectal Dis (2012) 1.01
The molecular rationale of Src inhibition in colorectal carcinomas. Int J Cancer (2013) 1.00
Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases. J Clin Endocrinol Metab (2012) 1.00
E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas. Anticancer Res (2004) 1.00
Primary hydatid disease of the gallbladder: a rare clinical entity. J Hepatobiliary Pancreat Surg (2004) 1.00
Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations. Int J Dermatol (2011) 1.00
Bone metastases: molecular mechanisms and novel therapeutic interventions. Med Res Rev (2010) 0.99
NF-kappaB/PPAR gamma and/or AP-1/PPAR gamma 'on/off' switches and induction of CBP in colon adenocarcinomas: correlation with COX-2 expression. Int J Colorectal Dis (2006) 0.99
Novel insights into the implication of the IGF-1 network in prostate cancer. Trends Mol Med (2005) 0.98
High incidence of MGMT and RARbeta promoter methylation in primary glioblastomas: association with histopathological characteristics, inflammatory mediators and clinical outcome. Mol Med (2009) 0.98
Breast cancer: the upgraded role of HER-3 and HER-4. Int J Biochem Cell Biol (2006) 0.98
Epigenetic effects of lung cancer predisposing factors impact on clinical diagnosis and prognosis. J Cell Mol Med (2008) 0.97
An extended retroperitoneal abscess caused by duodenal diverticulum perforation: report of a case and short review of the literature. Am Surg (2007) 0.97
The role of inflammation in heart failure: new therapeutic approaches. Hellenic J Cardiol (2011) 0.96
Accumulation of dietary glycotoxins in the reproductive system of normal female rats. J Mol Med (Berl) (2007) 0.96
Colon carcinogenesis: Learning from NF-kappaB and AP-1. Int J Biochem Cell Biol (2010) 0.96
Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis. Int J Colorectal Dis (2011) 0.96
Clinical considerations of primary hydatid disease of the pancreas. Pancreatology (2005) 0.96
Estrogen receptor beta (ERbeta) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm. J Cancer Res Clin Oncol (2004) 0.95
Renal dysgenesis and KAL1 gene defects in patients with sporadic Kallmann syndrome. Fertil Steril (2007) 0.95
FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities. Cancer Chemother Pharmacol (2006) 0.95
Primary melanoma of the gallbladder: does it exist? Report of a case and review of the literature. World J Gastroenterol (2006) 0.95
NF-κB in colorectal cancer. J Mol Med (Berl) (2013) 0.95
Histone modifications as a pathogenic mechanism of colorectal tumorigenesis. Int J Biochem Cell Biol (2012) 0.94
Inflammatory markers in hyperlipidemia: from experimental models to clinical practice. Curr Pharm Des (2011) 0.94
Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases. Curr Top Med Chem (2012) 0.93
Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) (2008) 0.93
Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome. J Bone Miner Metab (2010) 0.93
Expression of nuclear factor kappaB in human gastric carcinoma: relationship with I kappaB a and prognostic significance. Virchows Arch (2007) 0.93
The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study. Am J Kidney Dis (2006) 0.93
OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer. Mol Carcinog (2011) 0.93
SUMO and estrogen receptors in breast cancer. Breast Cancer Res Treat (2007) 0.93
Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway. Biochem Biophys Res Commun (2010) 0.92
Antiproliferative effect of exemestane in lung cancer cells. Mol Cancer (2009) 0.92
The glucocorticoid receptor signalling in breast cancer. J Cell Mol Med (2007) 0.92
Gracilis myocutaneous flap: evaluation of potential risk factors and long-term donor-site morbidity. Microsurgery (2011) 0.92
Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise. Expert Opin Investig Drugs (2010) 0.92
CHOP-dependent regulation of p21/waf1 during ER stress. Cell Physiol Biochem (2010) 0.92
The interleukin-6-174 promoter polymorphism is associated with a risk of development of Kaposi's sarcoma in renal transplant recipients. Anticancer Res (2004) 0.92